Global Advanced Research Journal of Medicine and Medical Sciences (GARJMMS) ISSN: 2315-5159
July 2016 Issue Vol. 5(7), pp. 203-207
Copyright © 2016 Global Advanced Research Journals
Full Length Research Paper
Cost Effectiveness of Outpatient Parenteral Antibiotic Therapy
Ibtisam Jali1* and Nisreen Bajnaid2
1Assistant professor internal medicine and rheumatology, King Abdulaziz University, Jeddah, Saudi Arabia.
2Assistant professor internal medicine and infectious diseases King Abdulaziz University, Jeddah, Saudi Arabia.
Accepted 04 July, 2016
*Corresponding Author E-mail: email@example.com; Mobile No.: +966506361988
Outpatient parenteral antibiotic therapy (OPAT) refers to the administration of parenteral antimicrobial in the non-inpatient setting with the explicit aim of facilitating early discharge. Establishing OPAT service in the medical floor in a governmental hospital was a cost effective project as the cost of all the patients involved in OPAT service is 6706 $ compared with 68,090 $ an estimated cost for in-hospital treatment. The most common organism was ESBL E-Coli (Extended Spectrum Beta Lactamase Escherichia coli). The most common antibiotic prescribed was Meropenem.
Keywords: Outpatient parenteral antibiotic therapy, Home parenteral antibiotic therapy, Cost-effectiveness.
List of Abbreviation
IV: intravenous; OPAT, Outpatient parenteral antibiotic therapy; HPAT, Home parenteral antibiotic therapy; ESBL E-Coli, Extended Spectrum Beta Lactamase Escherichia coli; PICC, peripherally inserted central catheter; KPC, Klebsiellapneumoniae carba penemase; MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, Methicillin-sensitive Staphylococcus aureus; UTI, urinary tract infection; BSI, bloodstream infection